menu
    • menu

    Company profile for Alaunos Therapeutics

    NEW Drugs in Dev: 10
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our robust and innovative discovery engine, we strike cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations. We have developed proprietary, rapid, cost-effective solutions to deliver tumor-specific killer T cells to large canc...
    Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our robust and innovative discovery engine, we strike cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations. We have developed proprietary, rapid, cost-effective solutions to deliver tumor-specific killer T cells to large cancer patient populations with unmet clinical need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alaunos TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8030 El Rio St Houston, TX 77054
    Telephone
    Telephone
    (212) 698-8802
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://alaunos.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ziopharm-oncology/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alaunos Reports ALN1003 Preclinical Data in Obesity Models
    Alaunos Reports ALN1003 Preclinical Data in Obesity Models

    18 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/18/3296589/18421/en/alaunos-reports-preclinical-aln1003-data-showing-effects-on-insulin-resistance-related-biomarkers-and-liver-histology-in-diet-induced-obesity-models.html

    GLOBENEWSWIRE
    18 May 2026
    Share Share
    Alaunos Therapeutics Reveals Promising ALN1003 Data
    Alaunos Therapeutics Reveals Promising ALN1003 Data

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247189/18421/en/Alaunos-Therapeutics-Announces-Positive-Preclinical-Proof-of-Concept-Data-for-ALN1003-a-Differentiated-Non-Hormonal-Oral-Treatment-for-Obesity-and-Related-Metabolic-Disorders.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Alaunos Therapeutics Announces $2.0M Direct Offering
    Alaunos Therapeutics Announces $2.0M Direct Offering

    23 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/23/3103328/18421/en/Alaunos-Therapeutics-Announces-2-0-Million-Registered-Direct-Offering.html

    GLOBENEWSWIRE
    23 Jun 2025
    Share Share
    Texas biotech axes cancer pact, pins hopes on obesity
    Texas biotech axes cancer pact, pins hopes on obesity

    11 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/after-axing-its-sole-clinical-prospect-last-year-alaunos-cuts-ties-precigen

    FIERCE BIOTECH
    11 Oct 2024
    Share Share
    Alaunos Therapeutics Announces Third Quarter 2023 Financial Results
    Alaunos Therapeutics Announces Third Quarter 2023 Financial Results

    14 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/14/2779968/18421/en/Alaunos-Therapeutics-Announces-Third-Quarter-2023-Financial-Results-Phase-1-Clinical-Data-and-Continued-Exploration-of-Strategic-Alternatives.html

    GLOBENEWSWIRE
    14 Nov 2023
    Share Share
    Alaunos winds down sole cell therapy trial, cuts 60% of staff
    Alaunos winds down sole cell therapy trial, cuts 60% of staff

    16 Aug 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/houston-biotech-winds-down-sole-clinical-stage-trial-cuts-60-its-staff

    Max Bayer FIERCE BIOTECH
    16 Aug 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search